| Dr Christopher Nemer Hage, MD | |
|
7345 Medical Center Dr, Suite 220, West Hills, CA 91307-1910 | |
| (818) 702-9962 | |
| (818) 702-0016 |
| Full Name | Dr Christopher Nemer Hage |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 7345 Medical Center Dr, West Hills, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043397482 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A90308 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Nemer Hage, MD Po Box 77790, Corona, CA 92877-0126 Ph: (951) 278-5590 | Dr Christopher Nemer Hage, MD 7345 Medical Center Dr, Suite 220, West Hills, CA 91307-1910 Ph: (818) 702-9962 |
News Archive
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and Ebola viruses.
A new assay capable of examining hundreds of proteins at once and enabling new experiments that could dramatically change our understanding of cancer and other diseases has been invented by a team of University of Chicago scientists.
Endovascular stents, stent grafts, and transcatheter heart valve (TAVI) devices provide enhanced methods for clinical treatment of cardiac and vascular disease. Further research and product development is currently ongoing worldwide to address complications associated with these devices.
Caraco Pharmaceutical Laboratories, Ltd. reports receipt of a proposal from Sun Pharmaceutical Industries Ltd. ("Sun") and Sun Pharma Global, Inc ("Sun Global") for a going private transaction by which Sun, Sun Global, and/or one or more of their affiliates would acquire all of the outstanding shares of Caraco common stock not held by Sun or Sun Global for a per share consideration of $4.75 in cash. This represents a 5% premium over the closing price of Caraco Common Stock on Dec 2, 2010.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
› Verified 1 days ago
Roger Amerian, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 7320 Woodlake Ave, Ste 290, West Hills, CA 91307 Phone: 818-716-6446 Fax: 818-716-9869 | |
Benjamin J Cohen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 23101 Sherman Pl, Suite 110, West Hills, CA 91307 Phone: 818-702-8800 Fax: 818-702-0080 | |
Dr. Jonathan Scott Matthew, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7301 Medical Center Dr, Suite 201, West Hills, CA 91307 Phone: 818-346-9911 Fax: 818-346-2857 | |
Barbara Callahan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7301 Medical Center Dr #402, West Hills, CA 91307 Phone: 818-227-0070 | |
Jon F Willen, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7230 Medical Center Dr, #203, West Hills, CA 91307 Phone: 818-226-6811 Fax: 818-226-6810 | |
Dr. Golnaz Saedi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7320 Woodlake Ave, Suite 170, West Hills, CA 91307 Phone: 818-888-7090 |